ALFUZZ D

ALFUZZ D is a combination medication containing Alfuzosin (10 mg) and Dutasteride (0.5 mg), formulated to manage the symptoms of benign prostatic hyperplasia (BPH) in adult men. Alfuzosin, an alpha-1 adrenergic blocker, relaxes the muscles in the prostate and bladder neck, facilitating easier urination. Dutasteride, a 5-alpha-reductase inhibitor, reduces the size of the enlarged prostate by decreasing levels of dihydrotestosterone (DHT), a hormone linked to prostate growth. 

Key Benefits:

• Alleviates urinary symptoms associated with BPH, such as difficulty in urination and frequent urination.

• Enhances urine flow and reduces the risk of acute urinary retention.

• Decreases the likelihood of requiring prostate surgery